The Cost Of Coupons? FDA To Study Impact of Incentive Programs In DTC Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency will evaluate whether price incentives in direct-to-consumer print ads affect perceptions of a product's risk.
You may also be interested in...
FDA’s DTC Coupon Study Triggers First Amendment Objections From PhRMA
FDA’s third attempt at studying the effects of coupons in direct-to-consumer print advertising triggers First Amendment concerns and raises the specter of regulatory restrictions based upon “potential deception,” according to the Pharmaceutical Research and Manufacturers of America.
FDA’s DTC Coupon Study Triggers First Amendment Objections From PhRMA
FDA’s third attempt at studying the effects of coupons in direct-to-consumer print advertising triggers First Amendment concerns and raises the specter of regulatory restrictions based upon “potential deception,” according to the Pharmaceutical Research and Manufacturers of America.
FDA To Study Impact of Coupons In Print DTC Ads
Study signals increasing agency efforts to monitor promotional activities for firms.